On Friday, Applied Therapeutics Inc (NASDAQ: APLT) was -7.59% down from the session before settling in for the closing price of $4.74. A 52-week range for APLT has been $0.88 – $9.39.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 52.74%. With a float of $89.01 million, this company’s outstanding shares have now reached $114.24 million.
Let’s look at the performance matrix of the company that is accounted for 25 employees.
Applied Therapeutics Inc (APLT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Applied Therapeutics Inc stocks. The insider ownership of Applied Therapeutics Inc is 22.09%, while institutional ownership is 52.03%. The most recent insider transaction that took place on Mar 14 ’24, was worth 1,717,108. In this transaction President and CEO of this company sold 318,573 shares at a rate of $5.39, taking the stock ownership to the 3,817,814 shares. Before that another transaction happened on Mar 14 ’24, when Company’s Chief Medical Officer sold 110,804 for $5.39, making the entire transaction worth $597,234. This insider now owns 1,031,537 shares in total.
Applied Therapeutics Inc (APLT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 47.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.74% per share during the next fiscal year.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
You can see what Applied Therapeutics Inc (APLT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.80. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 46.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.32, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Applied Therapeutics Inc (NASDAQ: APLT) saw its 5-day average volume 1.22 million, a negative change from its year-to-date volume of 1.99 million. As of the previous 9 days, the stock’s Stochastic %D was 7.03%. Additionally, its Average True Range was 0.46.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 34.08%, which indicates a significant increase from 0.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.52% in the past 14 days, which was lower than the 145.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.64, while its 200-day Moving Average is $3.07. Nevertheless, the first resistance level for the watch stands at $4.73 in the near term. At $5.07, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.25. If the price goes on to break the first support level at $4.20, it is likely to go to the next support level at $4.01. The third support level lies at $3.67 if the price breaches the second support level.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
There are 105,887K outstanding shares of the company, which has a market capitalization of 500.37 million. As of now, sales total 9,990 K while income totals -119,760 K. Its latest quarter income was -670 K while its last quarter net income were -37,680 K.
